News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

The Kansas City Beacon talked to Dr. Sarah Boyd about when you should get tested for the virus and what to do if you test positive.

What do I do if I’m exposed? How can I stay safe while traveling? What’s the difference between COVID and the flu? Dr. Sarah Boyd, infectious disease physician at Saint Luke's Health System, answers.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.

An expert with Saint Luke’s Comprehensive Multiple Sclerosis Center discusses early detection and exciting new advances in treatment.

Rhonda was hesitant to undergo a double lung transplant after learning about the risks. But thanks to an endobronchial valve procedure at Saint Luke's, Rhonda says she's been given another chance at life.

For three decades, breathing troubles followed James Seymore as he and his wife moved from one place to another. In 1980, he received his first diagnosis of pulmonary sarcoidosis in Wyoming. The inflammatory condition can cause shortness of breath, coughing, fatigue, and joint pain. His first bout resolved after a course of steroids, but it returned seven years later after the Seymores moved to Oregon.